Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Email Jeffrey Shuren at the FDA here in the US....

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Dec 09, 2021 11:08pm

163 Views

Post# 34217174

RE:Email Jeffrey Shuren at the FDA here in the US....

Is that FDA feller Ed's brother?

He sure turns out some toe-tappers.

If we follow the same TT ( TRIL trajectory) from 20 cents we'd only hit $18 CAD

Every 500 shares ( $100 today) would be worth $9,000 !

I'm thinking that with the CRRT stuff and all, we can maybe do a bit better!?

MM

<< Previous

Bullboard Posts

Next >>

Twelve Labs partners with AWS to revolutionize video search with AI